查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1645032

欧洲医药仓储：市场占有率分析、产业趋势与统计、成长预测（2025-2030 年）

Europe Pharmaceutical Warehousing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

欧洲医药仓储市场规模预计在 2025 年为 267.9 亿美元，预计到 2030 年将达到 398.5 亿美元，预测期内（2025-2030 年）的复合年增长率将超过 8.26%。

欧洲医药仓储-市场-IMG1

欧洲医药仓储市场正在发生快速变化，主要受对温度敏感物流的需求不断增加以及遵守严格监管标准的需求所推动。欧洲药品管理局 (EMA) 报告称，截至 2024 年 10 月，该地区核准的 85% 以上的药品需要特定的储存条件，包括精确的温度和湿度控制。这项要求正在刺激对尖端仓库管理技术的投资。此外，欧盟良好分销规范 (GDP) 指南强调了严格监控和记录药品储存的重要性。作为回应，许多设施开始整合支援物联网的系统以确保合规性。

根据欧盟委员会的资料，2023年受管制的药品中将有近60%对温度敏感。因此，全部区域冷藏设施的安装数量显着增加。 2023年1月至2024年8月期间，德国、法国和英国将共同建造超过20万立方公尺的冷藏容量。此外，为了解决劳动力短缺问题并提高业务效率，该行业正在采用机器人分类和气候控制区等自动化技术。

永续性措施也在整个市场引发了连锁反应。欧盟的一项新指令将于2024年中期生效，要求在2030年将氢氟碳化冷媒的使用量减少40%。这正在加速向更绿色的冷却技术的转变。到 2023 年，西班牙和荷兰 30% 以上的设施将采用太阳能供电。预计这些措施每年将减少至少 20% 的营运排放，与欧洲全面的环境目标相呼应。

欧洲医药仓储市场趋势

医药低温运输仓库扩建

由于严格的监管标准和对生技药品的需求激增，欧洲製药业高度重视低温运输物流。生技药品，包括疫苗和细胞/基因疗法，对温度变化极为敏感，需要仔细的温度控制。欧洲药品管理局 (EMA) 指出，截至 2024 年 3 月，生技药品占新药认证的近 30%，凸显了强大的低温运输基础设施的重要性。此外，欧盟 2023 年更新的良好分销规范 (GDP) 指南强调在整个供应链中严格控制温度，以保护产品效力并确保病患安全。

推动这一趋势的关键因素是对技术主导的低温运输系统的投资不断增加。德国和荷兰等国家已宣布计划在2024年2月前加强低温运输能力。尤其是德国，将从2022年起将其冷藏容量提高15%以上。透过物联网设备进行即时温度监控等进步正在涌现，重点是减少产品损失并确保遵守法规。这些努力与欧洲保持全球医药出口主导地位的雄心相呼应，预计 2023 年欧洲医药出口额将达到惊人的 2,230 亿欧元（2,489 亿美元）。

永续性倡议推动物流变革

在消费者需求和监管要求的推动下，永续性已成为欧洲医药物流领域关注的重点。 《欧洲绿色新政》旨在2030年实现，引导物流业走向电动车和替代燃料等低排放解决方案。欧盟委员会2024年3月发布的报告显示，物流业务占货运相关温室气体排放的25%以上，凸显了永续实践的迫切需求。法国和瑞典等国家正处于领先地位，法国在 2024 年 1 月取得了巨大进步，宣布投资 20 亿欧元（22 亿美元）用于绿色物流基础设施。

其中一个值得注意的倡议是转向电气化最后一哩配送解决方案。 2024 年 2 月，荷兰实现了一个重要里程碑，在全国推出了 10,000 多辆电动送货车。此外，铁路运输的发展势头日益强劲，众所周知，铁路运输排放的温室气体比道路运输少。截至2024年3月，奥地利通过铁路运输的药品数量与前一年同期比较大幅增加了20%。这些努力不仅减少了医药物流的碳排放，也与欧洲整体永续性目标相呼应。

欧洲医药仓储产业概况

欧洲医药仓储市场是一个分散的市场，由全球和本地参与者混合组成。大部分进出口产品在冷藏运送过程中都需要进行监控。供应商正在实施各种策略，例如策略联盟、伙伴关係、併购、地理扩张和产品/服务发布，以扩大其在市场上的影响力。主要企业包括 Bio Pharma Logistics、Rhenus SE and Co.KG、GEODIS SA 和 United Parcel Service Inc.

其他福利：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第 1 章 简介

  • 调查结果
  • 调查前提
  • 研究范围

第二章调查方法

第三章执行摘要

第四章 市场动态与洞察

  • 市场概况
  • 市场驱动因素
    • 外包医药仓储服务需求不断增加
    • 製药公司要求效率、可视性和产品安全性
  • 市场限制
    • 新兴国家缺乏高效率的物流支持
  • 市场机会
    • 政府加强加强医药仓储业务
  • 价值链/供应链分析
  • 产业吸引力－波特五力分析
    • 供应商的议价能力
    • 购买者/消费者的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手之间的竞争强度
  • 地缘政治与疫情将如何影响市场

第五章 市场区隔

  • 按类型
    • 低温运输仓库
    • 非低温运输仓库
  • 按应用
    • 药厂
    • 药局
    • 医院
    • 其他的
  • 按地区
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 其他欧洲国家

第六章 竞争格局

  • 市场集中度概览
  • 公司简介
    • Alloga
    • Bio Pharma Logistics
    • Rhenus SE and Co. KG
    • DB Schenker
    • FedEx Corp.
    • GEODIS SA
    • Hellmann Worldwide Logistics SE and Co KG
    • KRC Logistics
    • Kuehne Nagel Management AG
    • United Parcel Service Inc.
    • XPO Logistics Inc.

第七章：未来市场展望

第 8 章 附录

  • 宏观经济指标（GDP分布，依活动划分）
  • 经济统计 - 运输及仓储业对经济的贡献
  • 对外贸易统计 - 按商品、目的地和原产国分類的进出口数据
简介目录
Product Code: 50001492

The Europe Pharmaceutical Warehousing Market size is estimated at USD 26.79 billion in 2025, and is expected to reach USD 39.85 billion by 2030, at a CAGR of greater than 8.26% during the forecast period (2025-2030).

Europe Pharmaceutical Warehousing - Market - IMG1

The European pharmaceutical warehousing market is undergoing rapid changes, primarily due to the rising demand for temperature-sensitive logistics and the need to adhere to stringent regulatory standards. The European Medicines Agency (EMA) reported that, as of October 2024, more than 85% of the region's approved pharmaceutical products necessitate specific storage conditions, such as exact temperature and humidity controls. This requirement has led to heightened investments in cutting-edge warehousing technologies. Furthermore, the European Union's Good Distribution Practice (GDP) guidelines stress the importance of rigorous monitoring and documentation in pharmaceutical storage. In response, many facilities have begun integrating IoT-enabled systems to ensure compliance.

Cold chain warehousing is a primary focus, with data from the European Commission indicating that almost 60% of pharmaceuticals managed in 2023 were temperature-sensitive. Consequently, there's been a notable uptick in the establishment of refrigerated facilities across the region. Between January 2023 and August 2024, Germany, France, and the UK together contributed over 200,000 cubic meters to the cold storage capacity. In addition, to address labor shortages and boost operational efficiency, the industry is embracing automation advancements, including robotic sorting and climate-controlled zones.

Sustainability initiatives are also making waves in the market. New directives from the EU, effective mid-2024, call for a 40% cut in hydrofluorocarbon refrigerant usage by 2030. This has catalyzed a move towards greener cooling technologies. Renewable energy is becoming the norm for warehouses; in 2023, over 30% of facilities in Spain and the Netherlands adopted solar panels. Such measures are anticipated to reduce operational emissions by a minimum of 20% each year, resonating with Europe's overarching environmental ambitions.

Europe Pharmaceutical Warehousing Market Trends

Expansion of Cold Chain Storage for Pharmaceuticals

The European pharmaceutical sector is increasingly prioritizing cold chain logistics, driven by stringent regulatory standards and a surging demand for biologics. Biologics, which encompass vaccines and cell and gene therapies, are highly sensitive to temperature fluctuations, underscoring the need for meticulous temperature-controlled logistics. As of March 2024, the European Medicines Agency (EMA) highlighted the significance of a robust cold chain infrastructure, noting that biologics constituted nearly 30% of new drug approvals. Furthermore, the European Union's Good Distribution Practice (GDP) guidelines, updated in 2023, emphasize stringent temperature controls throughout the supply chain to safeguard product efficacy and ensure patient safety.

A pivotal factor fueling this trend is the escalating investment in technology-driven cold chain systems. By February 2024, nations like Germany and the Netherlands unveiled plans to bolster their cold chain capabilities. Notably, Germany has augmented its refrigerated storage capacity by over 15% since 2022. With a focus on reducing product spoilage and ensuring regulatory compliance, advancements like real-time temperature monitoring via IoT devices have emerged. These initiatives resonate with Europe's ambition to uphold its stature as a dominant player in global pharmaceutical exports, which reached an impressive EUR 223 billion (USD 248.9 billion) in 2023.

Sustainability Initiatives Driving Logistics Evolution

Sustainability has emerged as a pivotal focus in Europe's pharmaceutical logistics sector, propelled by consumer demand and regulatory mandates. The European Green Deal, targeting 2030, is steering the logistics industry towards low-emission solutions, such as electric vehicles and alternative fuels. Reports from the European Commission in March 2024 revealed that logistics operations account for over 25% of freight-related greenhouse gas emissions, highlighting the pressing need for sustainable practices. Leading the charge, countries like France and Sweden are making significant strides, with France unveiling a EUR 2 billion (USD 2.2 billion) investment in green logistics infrastructure in January 2024.

Among the notable initiatives is the shift towards electrified last-mile delivery solutions. The Netherlands marked a significant achievement in February 2024, rolling out over 10,000 electric delivery vehicles across the country. Furthermore, there's a growing momentum for rail transport, known for its lower greenhouse gas emissions compared to road transport. As of March 2024, Austria reported a 20% year-on-year surge in pharmaceutical goods transported via rail. These initiatives not only curtail the carbon footprint of pharmaceutical logistics but also resonate with Europe's overarching sustainability ambitions.

Europe Pharmaceutical Warehousing Industry Overview

The Europe Pharmaceutical Warehousing market is fragmented in nature, with a mix of global and local players. Most of the imports and exports products need to be monitored in refrigerated transports. Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. Major Players include Bio Pharma Logistics, Rhenus SE and Co. KG, GEODIS SA, and United Parcel Service Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS AND DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in demand for outsourcing pharmaceutical warehousing services
    • 4.2.2 Demand for efficiency, visibility, and product safety from pharmaceutical companies
  • 4.3 Market Restraints
    • 4.3.1 Lack of efficient logistics support in emerging economies
  • 4.4 Market Oppurtunites
    • 4.4.1 Rise in government initiatives to enhance Pharmaceutical Warehousing
  • 4.5 Value Chain / Supply Chain Analysis
  • 4.6 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.6.1 Bargaining Power of Suppliers
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Threat of New Entrants
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry
  • 4.7 Impact of Geopolitics and Pandemic on the Market

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Cold Chain Warehouse
    • 5.1.2 Non-Cold Chain Warehouse
  • 5.2 By Application
    • 5.2.1 Pharmaceutical Factory
    • 5.2.2 Pharmacy
    • 5.2.3 Hospital
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 Europe
      • 5.3.1.1 Germany
      • 5.3.1.2 UK
      • 5.3.1.3 France
      • 5.3.1.4 Russia
      • 5.3.1.5 Spain
      • 5.3.1.6 Rest of Europe

6 COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration Overview
  • 6.2 Company Profiles
    • 6.2.1 Alloga
    • 6.2.2 Bio Pharma Logistics
    • 6.2.3 Rhenus SE and Co. KG
    • 6.2.4 DB Schenker
    • 6.2.5 FedEx Corp.
    • 6.2.6 GEODIS SA
    • 6.2.7 Hellmann Worldwide Logistics SE and Co KG
    • 6.2.8 KRC Logistics
    • 6.2.9 Kuehne Nagel Management AG
    • 6.2.10 United Parcel Service Inc.
    • 6.2.11 XPO Logistics Inc.*

7 FUTURE OUTLOOK OF THE MARKET

8 APPENDIX

  • 8.1 Macroeconomic Indicators (GDP Distribution, by Activity)
  • 8.2 Economic Statistics - Transport and Storage Sector Contribution to Economy
  • 8.3 External Trade Statistics - Exports and Imports by Product and by Country of Destination/Origin